tiprankstipranks
Trending News
More News >
China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
Germany Market

China Resources Pharmaceutical Group Ltd. (640) Ratios

Compare
0 Followers

China Resources Pharmaceutical Group Ltd. Ratios

DE:640's free cash flow for Q4 2024 was HK$0.15. For the 2024 fiscal year, DE:640's free cash flow was decreased by HK$ and operating cash flow was HK$0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.25 1.33 1.25 1.25 1.20
Quick Ratio
1.03 1.09 1.03 1.04 1.00
Cash Ratio
0.18 0.18 0.18 0.18 0.14
Solvency Ratio
0.04 0.04 0.04 0.04 0.04
Operating Cash Flow Ratio
0.08 0.12 0.08 0.08 0.05
Short-Term Operating Cash Flow Coverage
0.30 0.34 0.30 0.29 0.12
Net Current Asset Value
HK$ 20.22BHK$ 9.37BHK$ 20.22BHK$ 23.92BHK$ 18.42B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.23 0.28 0.33 0.28
Debt-to-Equity Ratio
1.35 1.23 1.35 1.62 1.26
Debt-to-Capital Ratio
0.57 0.55 0.57 0.62 0.56
Long-Term Debt-to-Capital Ratio
0.17 0.23 0.17 0.12 0.04
Financial Leverage Ratio
4.87 5.37 4.87 4.88 4.51
Debt Service Coverage Ratio
0.34 0.28 0.34 0.24 0.20
Interest Coverage Ratio
3.79 5.09 3.79 3.41 2.68
Debt to Market Cap
1.17 1.89 1.17 2.08 2.13
Interest Debt Per Share
11.12 10.27 11.12 13.58 9.83
Net Debt to EBITDA
2.77 2.43 2.77 4.79 3.28
Profitability Margins
Gross Profit Margin
15.40%16.04%15.40%14.94%16.11%
EBIT Margin
4.85%4.54%4.85%3.85%5.00%
EBITDA Margin
6.09%5.71%6.09%5.04%6.22%
Operating Profit Margin
4.26%4.49%4.26%3.91%4.23%
Pretax Profit Margin
3.73%3.65%3.73%3.42%3.43%
Net Profit Margin
1.38%1.43%1.38%1.30%1.39%
Continuous Operations Profit Margin
2.93%2.88%2.93%2.67%2.55%
Net Income Per EBT
36.97%39.01%36.97%38.06%40.45%
EBT Per EBIT
87.56%81.34%87.56%87.52%81.09%
Return on Assets (ROA)
1.45%1.42%1.45%1.24%1.33%
Return on Equity (ROE)
7.06%7.62%7.06%6.04%5.98%
Return on Capital Employed (ROCE)
10.30%8.85%10.30%8.62%9.76%
Return on Invested Capital (ROIC)
6.01%6.02%6.01%4.93%4.55%
Return on Tangible Assets
1.87%1.59%1.87%1.62%1.73%
Earnings Yield
8.82%11.96%8.82%13.81%11.11%
Efficiency Ratios
Receivables Turnover
2.48 3.27 2.48 2.47 3.02
Payables Turnover
4.41 4.17 4.41 3.26 4.37
Inventory Turnover
7.23 7.12 7.23 6.78 6.84
Fixed Asset Turnover
10.27 10.66 10.27 9.27 8.85
Asset Turnover
1.05 1.00 1.05 0.95 0.96
Working Capital Turnover Ratio
7.32 6.89 7.32 7.92 7.90
Cash Conversion Cycle
115.15 75.19 115.15 89.78 90.78
Days of Sales Outstanding
147.40 111.48 147.40 147.90 121.01
Days of Inventory Outstanding
50.46 51.25 50.46 53.80 53.37
Days of Payables Outstanding
82.71 87.54 82.71 111.92 83.61
Operating Cycle
197.86 162.73 197.86 201.70 174.39
Cash Flow Ratios
Operating Cash Flow Per Share
1.73 2.48 1.73 1.79 1.00
Free Cash Flow Per Share
1.20 1.98 1.20 1.32 0.65
CapEx Per Share
0.53 0.50 0.53 0.46 0.35
Free Cash Flow to Operating Cash Flow
0.69 0.80 0.69 0.74 0.65
Dividend Paid and CapEx Coverage Ratio
2.54 3.79 2.54 3.07 2.16
Capital Expenditure Coverage Ratio
3.25 4.96 3.25 3.87 2.83
Operating Cash Flow Coverage Ratio
0.16 0.25 0.16 0.14 0.11
Operating Cash Flow to Sales Ratio
0.04 0.06 0.04 0.05 0.03
Free Cash Flow Yield
19.00%38.53%19.00%37.29%16.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.34 8.36 11.34 7.24 9.00
Price-to-Sales (P/S) Ratio
0.16 0.12 0.16 0.09 0.12
Price-to-Book (P/B) Ratio
0.80 0.64 0.80 0.44 0.54
Price-to-Free Cash Flow (P/FCF) Ratio
5.26 2.60 5.26 2.68 6.16
Price-to-Operating Cash Flow Ratio
3.64 2.07 3.64 1.99 3.98
Price-to-Earnings Growth (PEG) Ratio
1.13 2.76 1.13 0.47 0.00
Price-to-Fair Value
0.80 0.64 0.80 0.44 0.54
Enterprise Value Multiple
5.34 4.52 5.34 6.66 5.29
Enterprise Value
82.58B 69.74B 82.58B 79.56B 65.92B
EV to EBITDA
5.34 4.52 5.34 6.66 5.29
EV to Sales
0.33 0.26 0.33 0.34 0.33
EV to Free Cash Flow
10.95 5.62 10.95 9.57 16.24
EV to Operating Cash Flow
7.58 4.48 7.58 7.09 10.50
Tangible Book Value Per Share
5.87 11.59 5.87 5.88 5.03
Shareholders’ Equity Per Share
7.89 8.05 7.89 8.11 7.40
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.21 0.22 0.26
Revenue Per Share
40.45 43.04 40.45 37.69 31.90
Net Income Per Share
0.56 0.61 0.56 0.49 0.44
Tax Burden
0.37 0.39 0.37 0.38 0.40
Interest Burden
0.77 0.81 0.77 0.89 0.69
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.03 0.02 0.03 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 0.00
Income Quality
2.63 1.57 2.63 2.98 1.90
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis